Down 24% In A Month, Will Arvinas Stock Rebound?

Published on 2 Jun 2022 on Forbes

Larger pharmaceutical companies, Sanofi and Roche, have seen failures in their clinical trials for cancer treatments using oral selective estrogen...

Read the rest of the article

Start tracking your investments with Statfolio

Sanofi ( (SNY) ) has issued an announcement. Sanofi announced that the FDA has granted Breakthrou...

TipRanks · via Yahoo Finance 21 Dec 2024

Shares of Cytokinetics (NASDAQ:CYTK), Incorporated (NASDAQ:CYTK) climbed 4.8% after the company...

Investing.com 20 Dec 2024

Treatment with a Sanofi-Teva-partnered experimental drug meets the primary goals in a mid-stage...

Zacks · via Yahoo Finance 18 Dec 2024

Sanofi (SNY) saw its shares surge in the last session with trading volume being higher than avera...

Zacks · via Yahoo Finance 18 Dec 2024

Teva and Sanofi reported successful results in their phase 2 study of an IBD treatment. Both stoc...

Investing.com 18 Dec 2024

Teva stock soared 26.4% to 20.88 after briefly hitting its highest point since December 2018. San...

Investor's Business Daily 17 Dec 2024

Teva and Sanofi said they plan to launch a Phase 3 trial for duvakitug pending regulatory...

Investopedia · via Yahoo Finance 17 Dec 2024

On Tuesday, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Sanofi SA’s (NASDAQ:SNY) Phase 2b...

Benzinga · via Yahoo Finance 17 Dec 2024

Teva and its partner Sanofi say 47.8% of patients with ulcerative colitis who received a high dos...

Barrons.com 17 Dec 2024

Sanofi SNY announced that the FDA has granted a Breakthrough Therapy designation to its...

Zacks · via Yahoo Finance 13 Dec 2024